컨텐츠 바로가기

About iNtRON

㈜인트론바이오는 바이오신약 ‘R&BD 방향’을
‘사람대상’, ‘질병치료제’, ‘First-in-Class (MOA based)’로
설정하고 있으며, 이러한 방향을 지켜나가는 한,
“글로벌 R&D 그룹”으로서, 폭넓고, 자유롭게,
그리고 열정적으로 사업을 영위해 나갈 것입니다!
MORE

논문발표 현황

  • “Preclinical safety evaluation of intravenously administered SAL200 containing the recombinant phage endolysin SAL-1 as a pharmaceutical ingredient” Antimicrob. Agents Chemother. 58(4), 2084-2088, 2014

  • “Effect of gene amplifications in porphyrin pathway on heme biosynthesis in a recombinant Escherichia coli” J. Microbiol. Biotechnol. 23(5), 668-673, 2013

  • “Antibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1” Int. J. Antimicrob. Agents 41(2), 156-161, 2013

  • “Mannose-poly(ethylene glycol)-linked SPION targeted to antigen presenting cells for magnetic resonance imaging on lymph node” Carbohyd. Polym. 92(2), 1586-1595, 2013

  • “Porphyrin Derivatives from a Recombinant Escherichia coli Grown on Chemically Defined Medium” J. Microbiol. Biotechnol. 22(12), 1653-1658, 2012

  • “Carboxylic mannan-coated iron oxide nanoparticles targeted to immune cells for lymph node-specific MRI in vivo” Carbohyd. Polym. 88(2), 780-788, 2012

  • “Enhanced Detection of Coxiella burnetii with a Complementary Locked Primer-Based Real-Time PCR Method” Mol. Diagn. Ther., 15(2), 103-107, 2011

  • “Comparison of the Antibacterial Properties of Phage Endolysins SAL-1 and LysK” Antimicrob. Agents. Chemother., 55(4), 1764-1767, 2011

  • “Characterization of Staphylococcus aureus derived from bovine mastitis and isolation of two lytic bacteriophages” J. Gen. Appl. Microbiol, 56, 347-353, 2010

  • “Complete genome sequence of a newly isolated lytic bacteriophage, EFAP-1 of Enterococcus faecalis, and antibacterial activity of its endolysin EFAL-1” J. Appl. Microbiol. 108(5), 1769-1779, 2010